XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT INFORMATION
3 Months Ended
Dec. 31, 2014
SEGMENT INFORMATION [Abstract]  
SEGMENT INFORMATION
  5. SEGMENT INFORMATION

 

We operate in two principal segments – research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2014.

 

 

    Three Months Ended December 31,        
    2014     2013  
Revenue:                
Service   $ 4,398     $ 4,916  
Product     1,447       1,304  
    $ 5,845     $ 6,220  
                 
Operating income:                
Service   $ 18     $ 424  
Product     124       38  
    $ 142     $ 462  
                 
Interest Expense     (81 )     (164 )
Change in fair value of warrant liability – (increase) decrease     120       (961 )
Other income     2       1  
                 
Income (loss) before income taxes   $ 183     $ (662 )